Faze Medicines
Cambridge
About Faze Medicines
Faze Medicines is a biotechnology company that uses a variety of screening and proteomics techniques to define condensate interaction networks.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $81.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2020)
- Website: fazemed.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Chemical
Social Profiles
Canonical: https://fsome.com/organization/faze-medicines-49074 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.